General
Preferred name
CLONIXIN
Synonyms
Clonixic acid ()
Clonixin Lysinate ()
Lysine clonixinate ()
SCH-10304 ()
NSC-335505 ()
SCH 10304 ()
P&D ID
PD000098
CAS
55837-30-4
17737-65-4
Tags
natural product
drug
available
Drug Status
experimental
approved
Drug indication
Analgesic
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
INDICATION Indicated for use in the management of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.
Compound Sets
14
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
262.05
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
3.49
TPSA
62.22
Fraction CSP3
0.08
Chiral centers
0.0
Largest ring
6.0
QED
0.89
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Disease Area
rheumatology, infectious disease
Indication
pain relief
rheumatoid arthritis, soft tissue infection
Target
PTGS1, PTGS2
Immunology & Inflammation related
MOA
cyclooxygenase inhibitor
Source data